Title: Stress and depressive disorder: the role of excitatory synapses in its origin and treatment.

**Abstract**

Chronic stress leads to a weakening of excitatory synaptic transmission within and between multiple brain regions. In this talk I will discuss a model in which chronic stress impairs excitatory synapses in multiple sites with cortico-mesolimbic reward circuitry thereby producing depressive-like behavioral changes, such as anhedonia. In this model, weakening of excitatory synapses within and between the hippocampus (HC), prefrontal cortex, and nucleus accumbens (NAc) by chronic stress, ultimately resulting in decreased dopamine release from the ventral tegmental area, lowers the value of rewarding stimuli and promotes anhedonia.

Evidence of this defective circuitry-- both intrinsic to the NAc and at upstream synapses within CA1 of the HC- will be presented. In the HC, weakening of excitatory synapses is mediated by loss of GluA1-type AMPARs at distal apical dendrites in the temporoammonic-CA1 (TA-CA1) pathway, and is reversed by monoaminergic antidepressant treatment. Similarly, hippocampal output to the NAc is weakened and can be restored by both antidepressants and by high frequency activity-induced long-term potentiation.

Our model predicts that restoring excitatory drive in these synapses will restore the normal affective state, and we show chronic administration of fluoxetine exerts this action. We predicted that negative allosteric modulators of GABA receptors should also restore excitatory drive. Using behavioral, electrophysiological, and biochemical methods, we found that compounds that target α5 subunit-containing GABA-A receptors promoted synchronous oscillatory activity between the HC and NAc, restored excitatory strength at TA-CA1 synapses, and restored normative behavior in social interaction and sucrose preference tests following chronic stress, all within 24 hours of treatment. These data support an excitatory synapse hypothesis model in which depressive-like behavior is caused by dysfunctional cortico-mesolimbic circuitry, and suggests novel therapeutic approaches that may be capable of rapid antidepressant effects by restoring pathologically weakened synapses within reward circuits.
